The EDGE

Acute kidney injury in HCT: an update

J A Lopes, S Jorge and M Neves

Bone Marrow Transplant 2016 51: 755-762; advance online publication, February 8, 2016; 10.1038/bmt.2015.357

Commentaries

Long-term survival of patients with therapy-related myeloid neoplasms after allogeneic hematopoietic cell transplantation—more than just a myth

S Mukherjee and A T Gerds

Bone Marrow Transplant 2016 51: 763-764; advance online publication, May 9, 2016; 10.1038/bmt.2016.121

Transplantation in CLL: what we can learn from a dinosaur

P Dreger and E Montserrat

Bone Marrow Transplant 2016 51: 765-766; advance online publication, February 29, 2016; 10.1038/bmt.2016.27

The need for ‘onco-nephrology’ is increasing in hematopoietic stem cell transplantation

M Ando

Bone Marrow Transplant 2016 51: 767-768; advance online publication, March 21, 2016; 10.1038/bmt.2016.68

CLL: ibrutinib and transplantation ride together

E Montserrat and J Delgado

Bone Marrow Transplant 2016 51: 769-770; advance online publication, May 9, 2016; 10.1038/bmt.2016.118

Original Articles

ACUTE LEUKEMIA

Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation

J Finke, C Schmoor, H Bertz, R Marks, R Wäsch, R Zeiser and B Hackanson

Bone Marrow Transplant 2016 51: 771-777; advance online publication, January 11, 2016; 10.1038/bmt.2015.338

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

D Niederwieser, H Baldomero, J Szer, M Gratwohl, M Aljurf, Y Atsuta, L F Bouzas, D Confer, H Greinix, M Horowitz, M Iida, J Lipton, M Mohty, N Novitzky, J Nunez, J Passweg, M C Pasquini, Y Kodera, J Apperley, A Seber and A Gratwohl for the Worldwide Network of Blood and Marrow Transplantation (WBMT)

Bone Marrow Transplant 2016 51: 778-785; advance online publication, February 22, 2016; 10.1038/bmt.2016.18

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually OPEN

J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, R F Duarte, C Dufour, J Kuball, D Farge-Bancel, A Gennery, N Kröger, F Lanza, A Nagler, A Sureda and M Mohty for the European Society for Blood and Marrow Transplantation (EBMT)

Bone Marrow Transplant 2016 51: 786-792; advance online publication, February 22, 2016; 10.1038/bmt.2016.20

CHRONIC LEUKEMIA

Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation

C S Link, R Teipel, F Heidenreich, E Rücker-Braun, M Schmiedgen, J Reinhardt, U Oelschlägel, M von Bonin, J M Middeke, A Muetherig, K Trautmann-Grill, U Platzbecker, M Bornhäuser and J Schetelig

Bone Marrow Transplant 2016 51: 793-798; advance online publication, January 11, 2016; 10.1038/bmt.2015.339

Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study

M van Gelder, M H van Oers, W G Alemayehu, M C J Abrahamse-Testroote, J J Cornelissen, M E Chamuleau, P Zachée, M Hoogendoorn, M Nijland, E J Petersen, A Beeker, G-J Timmers, L Verdonck, M Westerman, O de Weerdt and A P Kater

Bone Marrow Transplant 2016 51: 799-806; advance online publication, February 15, 2016; 10.1038/bmt.2016.9

LYMPHOMA

Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL

S H Lim, S H Hyun, H S Kim, J Y Lee, K H Yoo, K S Jung, H-N Song, J Cho, S Park, Y H Ko, S J Kim, J Y Choi and W S Kim

Bone Marrow Transplant 2016 51: 807-812; advance online publication, February 8, 2016; 10.1038/bmt.2016.6

INHERITED AND GENETIC DISORDERS

Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors

U Anurathapan, S Hongeng, S Pakakasama, N Sirachainan, D Songdej, A Chuansumrit, P Charoenkwan, A Jetsrisuparb, K Sanpakit, P Rujkijyanont, A Meekaewkunchorn, Y Lektrakul, P Iamsirirak, P Surapolchai, W Satayasai, S Sirireung, R Sruamsiri, P A Wahidiyat, A Ungkanont, S Issaragrisil and B S Andersson

Bone Marrow Transplant 2016 51: 813-818; advance online publication, February 15, 2016; 10.1038/bmt.2016.7

GRAFT-VERSUS-HOST DISEASE

Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD

A Velasco-Guardado, A Mora-Soler, L López-Corral, O López-Godino, L Vázquez-López, O Blanco-Muñez, E Pérez-López, A Rodríguez-Pérez and D Caballero-Barrigón

Bone Marrow Transplant 2016 51: 819-824; advance online publication, March 7, 2016; 10.1038/bmt.2016.31

INFECTIONS

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT OPEN

D M Burns, S Rana, E Martin, S Nagra, J Ward, H Osman, A I Bell, P Moss, N H Russell, C F Craddock, C P Fox and S Chaganti

Bone Marrow Transplant 2016 51: 825-832; advance online publication, February 22, 2016; 10.1038/bmt.2016.19

QOL AND PATIENTS' CARE

Sexual function 1-year after allogeneic hematopoietic stem cell transplantation

K H Noerskov, I Schjødt, K L Syrjala and M Jarden

Bone Marrow Transplant 2016 51: 833-840; advance online publication, February 15, 2016; 10.1038/bmt.2015.342

Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation

S Mayo, H A Messner, S B Rourke, D Howell, J C Victor, J Kuruvilla, J H Lipton, V Gupta, D D Kim, C Piescic, D Breen, A Lambie, D Loach, F V Michelis, N Alam, J Uhm, L McGillis and K Metcalfe

Bone Marrow Transplant 2016 51: 841-847; advance online publication, February 29, 2016; 10.1038/bmt.2016.2

Letters to the Editor

Successful matched sibling cord blood transplant for ALL in a child with constitutional mismatch repair deficiency syndrome

J A Heath, M Campbell, K Tiedemann and P A Downie

Bone Marrow Transplant 2016 51: 848-849; advance online publication, January 25, 2016; 10.1038/bmt.2015.353

Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation

J A Yared, N Hardy, Z Singh, S Hajj, A Z Badros, M Kocoglu, S Yanovich, E A Sausville, C Ujjani, K Ruehle, C Goecke, M Landau and A P Rapoport

Bone Marrow Transplant 2016 51: 850-852; advance online publication, February 1, 2016; 10.1038/bmt.2015.346

Left ventricular mass and ambulatory blood pressure are increased in long-term survivors of childhood cancer after autologous SCT

A Vatanen, T H Ojala, T Sarkola, M Turanlahti, T Jahnukainen, U M Saarinen-Pihkala and K Jahnukainen

Bone Marrow Transplant 2016 51: 853-855; advance online publication, February 1, 2016; 10.1038/bmt.2015.355

A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen

G O'Kane, D Bracken-Clarke, N Gardiner, G Lee, M Ni Chonghaile, D Power, P A Daly, J McCaffrey, C L Bacon, E Conneally, C Flynn, E Vandenberghe, M J Kennedy, P V Browne, D M O'Donnell and P J Hayden

Bone Marrow Transplant 2016 51: 856-859; advance online publication, February 8, 2016; 10.1038/bmt.2015.354

Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants

S Masouridi-Levrat, F Simonetta, Y Beauverd, O Tsopra, Y Tirefort, C Stephan, E Levrat, M Ansari, F Verholen, E Roosnek, J R Passweg and Y Chalandon

Bone Marrow Transplant 2016 51: 860-862; advance online publication, February 8, 2016; 10.1038/bmt.2015.356

Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation

M Sarmiento, R Parody, F Márquez-Malaver, I Espigado, J Falantes, T Caballero, C Calderón, M Carmona, J López Haldon and J A Pérez-Simón

Bone Marrow Transplant 2016 51: 863-865; advance online publication, February 8, 2016; 10.1038/bmt.2016.8

Shortened apheresis-based extra-corporeal photochemotherapy for acute refractory GVHD in children: a prospective study

A Sauret, N Rabiau, E Rochette, V Grèze, P Halle, M Ouachée, J-H Dalle, E Seror, D Serraz, K Yakouben, D Adjaoud, A Pagnier, A Marie-Cardine-Bobbia, C Oudot, C Curtillet, M Poirée, J Kanold and E Merlin

Bone Marrow Transplant 2016 51: 866-868; advance online publication, February 8, 2016; 10.1038/bmt.2016.11

Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy

N Kawashima, Y Inamoto, T Sato, M Nakashima, Y Kagaya, K Watakabe, A Seto, N Fukushima, S Kurahashi, Y Ozawa and K Miyamura

Bone Marrow Transplant 2016 51: 869-871; advance online publication, February 15, 2016; 10.1038/bmt.2016.15

Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation

A Badbaran, B Fehse, M Christopeit, T Aranyossy, F A Ayuk, C Wolschke and N Kröger

Bone Marrow Transplant 2016 51: 872-873; advance online publication, February 15, 2016; 10.1038/bmt.2016.14

Chimerism interpretation with a highly sensitive quantitative PCR method: 6 months median latency before chimerism drop below 0.1%

D C Vicente, A B A Laranjeira, E C M Miranda, J A Yunes and C A de Souza

Bone Marrow Transplant 2016 51: 874-875; advance online publication, February 15, 2016; 10.1038/bmt.2016.5

Medullar toxicity after prolonged nitrous oxide exposure: an unexpected cause of bone marrow failure post allogeneic transplant

A Vozy, M Cohen, M T Rubio, S Rostaing-Rigattieri, M Mohty and A-C Mamez

Bone Marrow Transplant 2016 51: 876-878; advance online publication, February 22, 2016; 10.1038/bmt.2015.314

Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers

A Arai, C Sakashita, C Hirose, K-I Imadome, M Yamamoto, M Jinta, S Fujiwara, M Tomita, N Shimizu, T Morio and O Miura

Bone Marrow Transplant 2016 51: 879-882; advance online publication, February 22, 2016; 10.1038/bmt.2016.3

Changes in the autoantibody pattern during allogeneic stem-cell transplantation for acute myeloid leukemia complicated by systemic lupus erythematosus

K Arita, J Murakami, A Wada, T Miyazono and T Sugiyama

Bone Marrow Transplant 2016 51: 883-884; advance online publication, February 22, 2016; 10.1038/bmt.2016.21

Innovating consent for pediatric HCT patients

J Platt, D B Thiel, S L R Kardia and S W Choi

Bone Marrow Transplant 2016 51: 885-888; advance online publication, February 29, 2016; 10.1038/bmt.2016.10

Erratum

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

M C Oliveira, M Labopin, J Henes, J Moore, N Del Papa, A Cras, I Sakellari, R Schroers, H U Scherer, A Cuneo, S Kyrcz-Krzemien, T Daikeler, T Alexander, J Finke, M Badoglio, B Simões, J A Snowden and D Farge for the EBMT Autoimmune Diseases Working Party

Bone Marrow Transplant 2016 51: 889; 10.1038/bmt.2016.126

Corrigendum

Identification and validation of biomarkers associated with acute and chronic graft versus host disease

S S Ahmed, X N Wang, J Norden, K Pearce, E El-Gezawy, S Atarod, I Hromadnikova, M Collin, E Holler and A M Dickinson

Bone Marrow Transplant 2016 51: 890; 10.1038/bmt.2016.125